Screener
Monte Rosa Therapeutics, Inc. GLUE Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s prepaid & other current?
- Monte Rosa Therapeutics, Inc. (GLUE) reported prepaid & other current of $5.38M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s prepaid & other current changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s prepaid & other current decreased by 17.2% year-over-year, from $6.5M to $5.38M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s prepaid & other current?
- Over 4 years (2021 to 2025), Monte Rosa Therapeutics, Inc.'s prepaid & other current has grown at a 25.2% compound annual growth rate (CAGR), from $8.69M to $21.37M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Monte Rosa Therapeutics, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude